Ernexa Therapeutics Inc. (ERNAW) Gross profit 2023–2025
Ernexa Therapeutics Inc. (ERNAW) annual gross profit history from SEC filings — each fiscal year as reported.
$486,000FY2025 · since FY2023: $0 → $486,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $486,000 | +389.3% |
| FY2024 | -$168,000 | — |
| FY2023 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNAW financial trends
ERNAW RevenueERNAW Net incomeERNAW Net marginERNAW Gross marginERNAW Operating incomeERNAW Operating marginERNAW Operating cash flowERNAW Free cash flowERNAW Capital expendituresERNAW Return on equityERNAW Stock buybacksERNAW Dividends paidERNAW Total assetsERNAW Total liabilitiesERNAW Shareholders’ equityERNAW overview →